RAPT Therapeutics Inc (NASDAQ:RAPT)
| 16.55 Delayed Data As of 3:59pm ET |  +0.38 / +2.35%Today’s Change | 10.47 Today|||52-Week Range 31.45 | -16.41% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2017 | 2018 | -- | -- | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | -- | -- | -- |
| Depreciation And Amortization | 1.4M | 1.2M | -- | -- | ||
| Operating Expenses | Gross Income | -1.4M | -1.2M | -- | -- | |
| General Expenses | 27.9M | 35.7M | -- | -- | ||
| Research And Development | 25.6M | 31.8M | -- | -- | ||
| Total Operating Expenses | 29.3M | 36.9M | -- | -- | ||
| Non-Operating Expenses | Operating Income | -29.3M | -36.9M | -- | -- | |
| Other Expenses | 216.0K | 800.0K | -- | -- | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -29.1M | -36.1M | -- | -- | |
| Net Income | -29.1M | -36.1M | -- | -- | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 23.5M | 23.5M | -- | -- | |
| Shares To Calculate EPS Diluted | 23.5M | 23.5M | -- | -- | ||
| Earnings Per Share | EPS | -$1.24 | -$1.54 | -- | -- | |
| EPS Diluted | -$1.24 | -$1.54 | -- | -- | ||
